Stockscreener 앱 받기
3.22
11.81%
0.34
시간 외 거래:
3.25
0.03
+0.93%
전일 마감가:
$2.88
열려 있는:
$2.99
하루 거래량:
751.19K
Relative Volume:
0.21
시가총액:
$10.19M
수익:
$129.20K
순이익/손실:
$-7.44M
주가수익비율:
-0.2878
EPS:
-11.19
순현금흐름:
$-8.62M
1주 성능:
+14.59%
1개월 성능:
-27.96%
6개월 성능:
+102.52%
1년 성능:
-45.62%
1일 변동 폭
$2.75
$3.36
1주일 범위
$2.48
$3.36
52주 변동 폭
$1.08
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
명칭
Sonnet Biotherapeutics Holdings Inc
전화
609-375-2227
주소
100 OVERLOOK CENTER, PRINCETON, NJ
SONN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
3.22 | 18.67M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Sonnet Biotherapeutics Holdings Inc 주식(SONN)의 최신 뉴스
Sonnet Biotherapeutics Holdings Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
This Cancer Biotech Company Is Making a Big Bet on the HYPE Crypto. Should You Buy Its Stock Here? - Barchart.com
Sonnet BioTherapeutics Expands Clinical Study of SON-1010 in Combination with Atezolizumab for Advanced Platinum-Resistant Ovarian Cancer - Quiver Quantitative
Sonnet BioTherapeutics Expands Clinical Evaluation of - GlobeNewswire
Cancer Drug Shows 66% Response Rate in Ovarian Cancer Trial: Sonnet BioTherapeutics Advances to Higher Dose - Stock Titan
Live Chart Scan Detects Wedge Pattern in Sonnet BioTherapeutics Holdings Inc.Swing Trade Entry With Volume Triggers Released - beatles.ru
Is Sonnet BioTherapeutics Holdings Inc. stock overvalued or undervaluedRecord-breaking capital gains - Jammu Links News
What is the dividend policy of Sonnet BioTherapeutics Holdings Inc. stockBuild wealth faster with disciplined trading - Jammu Links News
Why is Sonnet BioTherapeutics Holdings Inc. stock attracting strong analyst attentionCapitalize on proven investment strategies - Jammu Links News
How strong is Sonnet BioTherapeutics Holdings Inc. company’s balance sheetFree Daily Trading Room Entry - Jammu Links News
What analysts say about Sonnet BioTherapeutics Holdings Inc. stockIdentify undervalued stocks poised to rally - Jammu Links News
What are the latest earnings results for Sonnet BioTherapeutics Holdings Inc.Fastest return on investment - Jammu Links News
What institutional investors are buying Sonnet BioTherapeutics Holdings Inc. stockExpert guidance for superior capital growth - Jammu Links News
What is the risk reward ratio of investing in Sonnet BioTherapeutics Holdings Inc. stockTransform your portfolio with high-yield stocks - Jammu Links News
What drives Sonnet BioTherapeutics Holdings Inc. stock priceStay ahead with daily market updates - Jammu Links News
What catalysts could drive Sonnet BioTherapeutics Holdings Inc. stock higher in 2025Dynamic profit expansion - Jammu Links News
Is it the right time to buy Sonnet BioTherapeutics Holdings Inc. stockHigh-velocity gains - Jammu Links News
Sonnet BioTherapeutics Appoints Interim CEO Raghu Rao - TipRanks
Sonnet BioTherapeutics enters employment agreement with interim CEO Raghu Rao - Investing.com Australia
Is this a good reentry point in Sonnet BioTherapeutics Holdings Inc.Earnings Play Trade Plan With Alerts Shared - metal.it
Is Sonnet BioTherapeutics Holdings Inc. a growth stock or a value stockBest Dividend Insights For Fast Growth - Jammu Links News
Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attentionSmart Money Tracking Signal Generator Activated - beatles.ru
Real time social sentiment graph for Sonnet BioTherapeutics Holdings Inc.Daily Smart Money Movement Monitor Activated - metal.it
Published on: 2025-07-30 03:59:14 - metal.it
Published on: 2025-07-29 23:38:09 - metal.it
Published on: 2025-07-29 20:04:07 - metal.it
Pattern Scan Adds Sonnet BioTherapeutics Holdings Inc. to WatchlistWealth Building Stock Market Ideas Based on Momentum - beatles.ru
Analyzing net buyer seller activity in Sonnet BioTherapeutics Holdings Inc.Insider Strategy for High Conviction Picks - Newser
Sonnet BioTherapeutics Holdings Inc. Company Revenue and Profit Trends: A Deep DiveWeekly Double Return List - metal.it
How Interest Rate Changes Impact Sonnet BioTherapeutics Holdings Inc. Stock PerformanceFree Access to Community - Newser
Top Risks to Consider Before Buying Sonnet BioTherapeutics Holdings Inc. StockFree Deep Market Trend Analysis - Newser
Sonnet BioTherapeutics Regains Nasdaq Compliance After Fundraising - The Globe and Mail
Sonnet BioTherapeutics Holdings Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - PrintWeekIndia
Is Sonnet BioTherapeutics Holdings Inc. a good long term investmentFree Capital Efficiency Planning - PrintWeekIndia
How Sonnet BioTherapeutics Holdings Inc. stock performs during market volatilityFree Market Analysis Group - Newser
Sonnet Biotherapeutics Holdings Inc (SONN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):